Publikationen in Zusammenarbeit mit Forschern von University of Sydney (4)

2023

  1. ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients with Relapsed or Refractory Follicular Lymphoma

    Journal of Clinical Oncology

2022

  1. Romidepsin Plus CHOP Versus CHOP in Patients With Previously Untreated Peripheral T-Cell Lymphoma: Results of the Ro-CHOP Phase III Study (Conducted by LYSA)

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 3, pp. 242-251

2021

  1. Incidence of central nervous system relapses in patients with dlbcl treated with lenalidomide as maintenance after r-chop

    Blood Advances

2019

  1. Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: Long-term results of the PRIMA study

    Journal of Clinical Oncology, Vol. 37, Núm. 31, pp. 2815-2824